The complex inhibitory mechanism of glycomimetics with human heparanase
Whitefield, C.; Vo, Y.; Schwartz, B. D.; Hepburn, C.; Ahmed, F. H.; Onagi, H.; Banwell, M. G.; Nelms, K.; Malins, L. R.; Jackson, C. J.
Show abstract
Heparanase (HPSE) is the only mammalian endo-{beta}-glucuronidase known to catalyse the degradation of heparan sulfate. Dysfunction of HPSE activity has been linked to several disease states, resulting in HPSE becoming the target of numerous therapeutic programs, yet no drug has passed clinical trials to date. Pentosan polysulfate sodium (PPS) is a heterogeneous FDA-approved drug for the treatment of interstitial cystitis and a known HPSE inhibitor. However, due to its heterogeneity, characterisation of its mechanism of HPSE inhibition is challenging. Here we show that inhibition of HPSE by PPS is complex, involving multiple overlapping binding events, each influenced by factors such as oligosaccharide length and inhibitor-induced changes in protein secondary structure. The present work advances our molecular understanding of the inhibition of HPSE, which will aid the development of therapeutics for the treatment of a broad range of pathologies associated with enzyme dysfunction including cancer, inflammatory disease and viral infections.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Evaluation of Alphafold modeling for elucidation of nanobody-peptide epitope interactions 95%
- Biochemical characterization of Bacillus anthracis sortase B: Use in sortase mediated ligation and substrate recognition dependent on residues beyond the canonical pentapeptide binding motif for sortase enzymes 95%
- Novel exported bifunctional fusion enzymes with chorismate mutase and cyclohexadienyl dehydratase activity: shikimate pathway enzymes teamed up in no man's land 95%
Similar papers in this journal
- Screening macrocyclic peptide libraries by yeast display allows control of selection process and affinity ranking 95%
- Potent and Selective SETDB1 Covalent Negative Allosteric Modulator Reduces Methyltransferase Activity in Cells 95%
- Illuminating the mechanism and allosteric behavior of NanoLuc luciferase 95%
Similar papers in this journal
- Conformational modulation of a mobile loop controls catalysis in the (βα)8-barrel enzyme of histidine biosynthesis HisF 94%
- Substrate dynamics contribute to enzymatic specificity in human and bacterial methionine adenosyltransferases 94%
- Changes in Active Site Loop Conformation Relate to the Transition toward a Novel Enzymatic Activity 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.